Cirtran (CIRX) AI Stock Analysis

Cirtran

(Other OTC:CIRX)

Select Model

Rating:37Underperform

Price Target:$0.02▼(-13.04% Downside)

Action:reiterated

Date:09/25/26

The overall score is at the minimum threshold, reflecting a company in severe financial distress. The most significant factor is the insolvent balance sheet and negative operating cash flow, which pose an existential risk. This is compounded by bearish technicals and a valuation that signals a lack of market confidence. The recent reported profit is overshadowed by the company's inability to generate cash from operations.

Positive Factors

Revenue GrowthAccelerating TTM revenue indicates improving demand for the company’s services and a broader operating base. If sustained, this growth can provide greater scale for manufacturing and fulfillment activities, support fixed-cost absorption, and strengthen the foundation for future earnings improvement.

Negative Factors

Negative EquityDeeply negative equity signals an impaired capital structure and materially limits financial flexibility. It can make additional financing more difficult, increase solvency concerns, and restrict the company’s ability to fund growth or withstand continued operating weakness without outside support.

Cirtran (CIRX) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $114.49K
Dividend Yield: ―
Average Volume (3M): 19.69K
Price to Earnings (P/E): 0.1
Beta (1Y): -1.88
Revenue Growth: 336.70%
EPS Growth: ―
Country: US
Employees: 4
Sector: Industrials
Sector Strength: 63
Industry: Food Distribution

Cirtran Business Overview & Revenue Model

Company Description

CirTran Corporation provides manufacturing, marketing, distribution, and technology services for consumer products, including tobacco products, medical devices, and beverages worldwide. The company manufactures, distributes, and sells condoms, electr...

How the Company Makes Money

CirTran’s revenue model is primarily based on charging customers for outsourced operational services. This typically includes (1) electronics manufacturing services (EMS) fees for contract manufacturing, assembly, testing, and related production acti...

Cirtran Financial Statement Overview

Summary

Financial health is critically weak. While TTM revenue grew and a net profit was reported, the balance sheet is insolvent with -$23M in equity, and operating cash flow is deeply negative at -$586.5K, indicating the core business is burning cash and earnings quality is poor.

Income Statement

35Negative

Balance Sheet

5Very Negative

Cash Flow

10Very Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.83M	3.13M	1.30M	1.62M	1.72M	2.92M
Gross Profit	2.27M	1.54M	838.64K	1.01M	1.02M	1.90M
EBITDA	414.47K	276.37K	-1.75M	221.70K	-562.15K	-126.73K
Net Income	2.13M	-701.63K	-2.63M	20.29M	-1.35M	-627.38K
Balance Sheet
Total Assets	2.60M	2.51M	1.53M	1.85M	2.00M	1.46M
Cash, Cash Equivalents and Short-Term Investments	158.14K	9,589	30.38K	0	18.08K	5,472
Total Debt	3.49M	3.43M	3.36M	3.22M	3.16M	3.22M
Total Liabilities	25.60M	27.62M	25.94M	23.63M	44.07M	42.03M
Stockholders Equity	-22.99M	-25.11M	-24.41M	-21.78M	-42.07M	-40.56M
Cash Flow
Free Cash Flow	-586.50K	-1.34M	-46.35K	-81.02K	159.30K	340.66K
Operating Cash Flow	-586.50K	-1.34M	-46.35K	-72.61K	159.30K	344.46K
Investing Cash Flow	0	0	15.40K	-8,414	0	-3,798
Financing Cash Flow	740.30K	1.35M	30.95K	62.94K	-146.69K	-443.33K

Cirtran Technical Analysis

Technical Analysis SentimentNegative

Last Price0.02

Price Trends

50DMA0.03Negative

100DMA0.03Negative

200DMA0.03Negative

Market Momentum

MACD-0.00Negative

RSI40.68Neutral

STOCH-0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CIRX, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 40.68 is Neutral, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CIRX.

Cirtran Risk Analysis

Cirtran disclosed 16 risk factors in its most recent earnings report. Cirtran reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Cirtran Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

CIRX against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RCMT	69Neutral	$250.44M	15.62	37.92%	―	11.24%	31.12%
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
NNBR	61Neutral	$368.41M	-4.28	-27.06%	―	13.92%	29.66%
TUSK	56Neutral	$153.05M	11.18	5.22%	―	-46.29%	88.49%
TRC	53Neutral	$442.61M	71.66	1.27%	―	25.45%	―
CODI	47Neutral	$838.88M	-5.64	-21.01%	―	8.37%	51.01%
CIRX	37Underperform	$114.49K	0.05	-8.82%	―	336.70%	―

* Industrials Sector Average

Performance Comparison

CIRX and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
CIRX	Cirtran Corp	0.02	0.00	15.00%
CODI	Compass Diversified	11.67	5.67	94.50%
NNBR	NN Inc	3.72	1.92	106.67%
RCMT	RCM (RCMT)	34.99	11.93	51.73%
TRC	Tejon Ranch	16.23	0.65	4.17%
TUSK	Mammoth Energy Services Inc	3.10	1.05	51.22%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 25, 2026

Cirtran AI Stock Analysis